SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001544227-21-000018
Filing Date
2021-03-29
Accepted
2021-03-29 07:38:28
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mlnd-20201231.htm   iXBRL 10-K 1338883
2 EX-10.29 mlnd-20201231xex1029.htm EX-10.29 36483
3 EX-10.30 mlnd-20201231xex1030.htm EX-10.30 88125
4 EX-10.31 mlnd-20201231xex1031.htm EX-10.31 89369
5 EX-10.32 mlnd-20201231xex1032.htm EX-10.32 90531
6 EX-21.1 mlnd-20201231xex211.htm EX-21.1 4796
7 EX-23.1 mlnd-20201231xex231.htm EX-23.1 9839
8 EX-31.1 mlnd-20201231xex311.htm EX-31.1 10165
9 EX-31.2 mlnd-20201231xex312.htm EX-31.2 10195
10 EX-32.1 mlnd-20201231xex321.htm EX-32.1 7236
  Complete submission text file 0001544227-21-000018.txt   5913217

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlnd-20201231.xsd EX-101.SCH 38383
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlnd-20201231_cal.xml EX-101.CAL 70801
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlnd-20201231_def.xml EX-101.DEF 161671
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlnd-20201231_lab.xml EX-101.LAB 562486
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlnd-20201231_pre.xml EX-101.PRE 322891
16 EXTRACTED XBRL INSTANCE DOCUMENT mlnd-20201231_htm.xml XML 692639
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35890 | Film No.: 21779478
SIC: 2834 Pharmaceutical Preparations